BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Hansa Biopharma Completes Phase 3 Trial Enrollment Ahead of Schedule for Rare Autoimmune Disease

Hansa Biopharma, "Hansa" announced it has completed the enrolment of patients in the GOOD-IDES-02 trial, a global pivotal Phase 3 trial in anti-glomerular ...

December 06, 2024 | News

NTC Announces Positive Phase II Results for NTC014 in Bacterial Conjunctivitis Treatment

NTC, an international R&D focused pharmaceutical company headquartered in Italy, presents positive results from Phase II MIRAKLE study, a mul...

December 06, 2024 | News

QIAGEN Launches Industry-First Custom Digital PCR and NGS Panel Design Tools for Advanced Microbial Applications

QIAGEN introduces market’s first customizable digital PCR assay design tool with advanced design algorithms tailored for diverse microbial applicat...

November 29, 2024 | News

Vaxxas Expands Global Patent Portfolio to 42, Securing Exclusive Rights to HD-MAP Vaccination Technology

-Vaxxas, a clinical-stage biotechnology company, has expanded its global intellectual property portfolio to 42 patents, supporting its exclusive claim to m...

November 25, 2024 | News

GenScript Biotech Hosts European Debut of Global Forum, Driving Collaboration in Cell and Gene Therapy Innovation

GenScript Biotech Corporation, a global leader in life sciences R&D and manufacturing services, successfully hosted the European debut of its GenS...

November 22, 2024 | Report

Samsung Biologics Secures USD 668 Million in Manufacturing Deals with Europe, Surpasses USD 4 Billion in 2024 Global Contract Value

The company will provide manufacturing services through 2031 in deals worth over USD 668 million Samsung Biologics' cumulative contract value for 2...

November 20, 2024 | News

South Korea’s Celltrion Acquires iQone Healthcare Switzerland to Boost Direct Commercialization of Biosimilars in Europe

Celltrion announces acquisition of iQone Healthcare Switzerland, accelerating direct commercialization of its biosimilars in the European region T...

November 18, 2024 | News

SEKISUI Diagnostics Completes £15.7 Million cGMP Expansion for Enhanced Microbial Drug Substance Manufacturing in the UK

SEKISUI Diagnostics' microbial CDMO business announces it has completed construction of its £15.7 million ($20.7 million) cGMP capacity expansion&nbs...

November 15, 2024 | News

Australia’s Aravax Establishes UK Subsidiary to Advance Allergy Immunotherapies

Aravax, a clinical-stage biotechnology company developing next-generation immunotherapies designed to be safe, convenient, and precisely targeted, today an...

November 14, 2024 | News

DEBx Medical Secures New Investment Round Led by TVM Capital Healthcare to Accelerate Expansion in Europe, MENA, and Global Markets

DEBx Medical, an Amsterdam-based leader in advanced wound care, has announced the successful completion of its second investment round, spearheaded by TVM ...

November 14, 2024 | News

Ascend Advanced Therapies Partners with EW Healthcare to Bolster US Footprint and Integrate ABL’s Expertise in Viral Vector Manufacturing

Ascend Advanced Therapies (Ascend), a gene-to-GMP development partner, has partnered with EW Healthcare Partners to expand the footprint and capa...

November 13, 2024 | News